GROW WITH US
Why UIZ.CARE Is Investable Now
UIZ.CARE is building the clinical intelligence infrastructure layer for primary care.
The company enters the healthcare market through one of its most urgent and structurally underserved challenges: youth mental health. However, the long-term opportunity extends far beyond mental health itself. UIZ.CARE is designed to help healthcare systems identify, structure, triage, monitor, and coordinate emotional, behavioral, cognitive, and physiological health signals before they escalate into more complex and costly interventions.
Its architecture combines patient engagement, clinician decision support, interoperability, population intelligence, and regulatory-grade AI governance within a single platform. This positions UIZ.CARE not as a standalone application, but as a foundational layer capable of supporting the evolution of primary care from reactive treatment toward predictive and preventive healthcare.
What makes UIZ.CARE investable today is that a substantial portion of the highest-risk early-stage work has already been completed.
Over the past several years, the company has progressed beyond concept validation through pilot execution, workflow testing, implementation learning, product refinement, interoperability development, and the establishment of an initial regulatory and evidence-generation foundation. The central question is therefore no longer whether the problem exists or whether healthcare professionals recognize the need. The next stage is focused on converting validated groundwork into regulatory progression, reimbursement readiness, commercial deployment, and scalable market adoption.
The underlying market drivers are structural rather than cyclical.
Across Europe, primary-care systems face rising demand, workforce shortages, increasing mental-health burden, growing administrative pressure, and escalating healthcare costs. Youth mental health has emerged as one of the most visible manifestations of these pressures. Young people frequently enter care late, struggle to articulate symptoms, and move between informal support and clinical intervention without continuity. At the same time, healthcare professionals operate under significant time constraints while attempting to manage increasingly complex psychosocial needs.
This creates demand for infrastructure that improves signal capture, supports earlier recognition, structures care pathways, and reduces avoidable escalation without increasing clinician workload.
UIZ.CARE is positioned precisely within this transition.
Its deployment model is designed around workflow integration, explainable AI, interoperability standards, evidence generation, and reimbursement alignment. Rather than pursuing growth through consumer acquisition alone, the company is building a payer-aligned and institutionally credible pathway toward long-term adoption. Commercialization is structured around healthcare providers, care networks, insurers, and public-health stakeholders that benefit directly from improved care coordination, earlier intervention, and more efficient resource utilization.
The current financing round is intended to accelerate the company's progression through its next major value inflection point.
Capital will be deployed toward:
MDR regulatory progression and compliance activities;
EU AI Act readiness and governance implementation;
Clinical validation and evidence generation;
Expansion of interoperability and integration capabilities;
Commercialization within the Netherlands;
Preparation for entry into Germany and other European markets.
From an investor perspective, UIZ.CARE sits at a particularly attractive stage of development.
Much of the foundational risk associated with healthcare innovation has already been reduced through years of pilot execution and implementation learning. At the same time, the largest value-creation opportunities remain ahead through regulatory advancement, reimbursement access, institutional contracting, market penetration, and geographic expansion.
Importantly, the company's long-term defensibility is not expected to arise from artificial intelligence alone. AI models will continue to evolve across the industry. UIZ.CARE's defensibility is expected to emerge from the combination of real-world healthcare workflow integration, longitudinal data accumulation, interoperability, clinical evidence, regulatory readiness, reimbursement positioning, and trusted institutional relationships. Together, these elements create barriers to replication that strengthen over time.
The investment opportunity therefore extends beyond funding a digital-health product.
Investors are supporting the development of a clinical intelligence infrastructure platform designed to serve as a foundational component of next-generation primary care. Youth mental health is the entry point. Clinical intelligence infrastructure is the destination.
The capital raised today is intended to accelerate a transition already underway: from validated pilot platform to institutionally credible, reimbursement-ready healthcare infrastructure company capable of scaling across European healthcare systems.
Investment Thesis
UIZ.CARE is investable now because it has already completed a substantial share of the highest-risk groundwork required in regulated healthcare innovation and is entering a stage where capital can unlock disproportionate value through regulatory progression, evidence maturity, reimbursement readiness, commercial deployment, and scalable market expansion.
The company is positioned at the intersection of four long-term growth drivers:
The digital transformation of primary care;
The rising demand for mental-health support;
The emergence of clinical artificial intelligence;
The transition toward predictive and preventive healthcare systems.
This convergence creates the potential for UIZ.CARE to evolve from a focused youth mental-health solution into a broader clinical intelligence infrastructure platform serving healthcare providers, payers, and health systems at scale.
